Brief: Active Biotech carries out 48 mln SEK rights issue

Active Biotech AB publ

15/02/2018 07:31

Feb 15 (Reuters) - Active Biotech Ab  ACTI.ST : 
    * ACTIVE BIOTECH CARRIES OUT RIGHTS ISSUE 
    * ACTIVE BIOTECH AB SAYS  HAS RESOLVED TO MAKE A RIGHTS 
ISSUE OF 
APPROXIMATELY SEK 48 MILLION BEFORE ISSUE COSTS 
    * ACTIVE BIOTECH AB SAYS SHAREHOLDERS SHALL BE ENTITLED TO 
SUBSCRIBE FOR THE NEW SHARES WITH PRE-EMPTIVE RIGHTS, WHEREBY 
TWO EXISTING SHARES SHALL ENTITLE TO SUBSCRIPTION FOR ONE NEW 
SHARE 
    * ACTIVE BIOTECH AB SAYS  SUBSCRIPTION PRICE SHALL BE SEK 1 
PER 
SHARE 
    * ACTIVE BIOTECH AB SAYS COMPANY HAS ENTERED SUBSCRIPTION 
COMMITMENTS AND ISSUE GUARANTEE OF APPROXIMATELY SEK 30 MILLION, 
CORRESPONDING TO APPROXIMATELY 61 PERCENT OF THE RIGHTS ISSUE 
    * ACTIVE BIOTECH SAYS RIGHTS ISSUE AIMS AT PROVIDING THE 
FINANCIAL 
STABILITY REQUIRED TO AWAIT THE OUTCOME OF ONGOING CLINICAL 
STUDIES AND TO CONDUCT NEGOTIATIONS WITH PARTNERS REGARDING 
OTHER DEVELOPMENT PROJECTS 
 
Source text for Eikon:  ID:nGNE3rQ66w  
Further company coverage:  ACTI.ST  
 
 (Reporting By Anna Ringstrom) 
 ((Anna.Ringstrom@thomsonreuters.com;))